Pfizer Stock News

Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant. Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed. Investors on wall street

TOKYO: Japan''s Nikkei share average slipped on Thursday as investors turned cautious ahead of key central bank meetings next week, although strong gains for airlines limited losses with Omicron fears continuing to recede. The Nikkei 225 declined 0.15% to 28,818.53 as of the lunch break, but had earlier touched a nearly two-week intraday high of 28,908.29. The U.S. Federal Reserve headlines a string of central bank policy decisions next week, which also includes the Bank of Japan and European Central Bank. Investors seem to want to take time to judge the direction of financial markets with so many key central banks meetings next week, so they are adopting a wait-and-see approach, said Masahiro Ichikawa, chief market strategist at Sumitomo Mitsui DS Asset Management. The 200-day moving average is putting a tight lid on gains. The 200-day moving average provided stiff resistance at 28,895.39, as investors took a breather following a more than 4% rally from last Thursday''s close. The broader Topix sank 0.33%, with metal products , textiles and machinery stocks leading declines.

The South African Health Products Authority (SAHPRA) on Wednesday approved the use of Pfizer''s Comirnaty COVID vaccine after BioNTech and Pfizer announced that two doses of their vaccine may not be enough to protect against Omicron.

New Zealand Prime Minister Admits "There''s Not Going To Be An End Point To This Vaccination Program" Authored by Paul Joseph Watson via Summit News, New Zealand Prime Minister Jacinda Ardern has candidly revealed that theres not going to be an end point to this vaccination program. Yes, really. So long as theres people who are eligible who havent been vaccinated, weve got work to do, said Ardern. Do you know, I dont think Ill ever be satisfied so long as theres someone who is eligible and hasnt been (vaccinated), she added. NEW - "Theres not going to be an endpoint to this vaccination program," says New Zealand PM Jacinda Ardern. pic.twitter.com/YdjZEIBGFx Disclose.tv (@disclosetv) December 7, 2021 Theres not going to be an end point to this vaccination program, the Prime Minister revealed, while calling on people who got jabbed six months ago to come back for another shot. Ardern delivered the message while adopting her familiar passive-aggressive smiley mannerism, as seen many times before when she casually revealed the next step in COVID authoritarianism.

BioNTech and Pfizer said that a preliminary laboratory study demonstrated a three-shot course of their COVID-19 vaccine generates a neutralising effect against the new Omicron variant in a laboratory test.

Three doses of Pfizer vaccine likely to protect against Omicron infection, tests suggest Initial findings indicate stark reduction in protection against new Covid variant from two vaccine doses Coronavirus The post Three doses of Pfizer likely to protect against Omicron, tests suggest appeared first on Nigeria''s Top News Site .

Latest figures come amid concern over spread of Omicron variant; Pfizer says third jab increased antibodies by factor of 25 Three Pfizer jabs likely to protect against Omicron, tests suggest The post Covid news: UK reports 51,342 new infections; vaccines protect against new variant as it happened appeared first on Nigeria''s Top News Site .

The companys finding is based on only a small study of blood samples in a laboratory, but others are sure to follow.

Three doses of Pfizer''s mRNA vaccine can knock back the omicron variant by producing a 25-fold increase in antibodies, the company announced, but said two doses might not be enough to keep the mutant at bay.

Welcome to Wednesdays Overnight Health Care, where were following the latest moves on policy and news affecting your health. Subscribe here: thehill.com/newsletter-signup.Santa Claus is good to go and even more protected against COVID-19 after

We answer your questions about the omicron variant''s symptoms and the effectiveness of Pfizer and Moderna boosters against omicron.

The number of active cases of covid19 continues to climb, now standing at 13,321. The recorded figure of 881 new cases on Wednesday is the second highest thus far in the pandemic period. The new cases were from samples taken between Sunday to Tuesday. The death toll is now 2,320 with 17 deaths recorded between Tuesday and Wednesday. The highest recorded number of daily covid19 cases was 984 on Saturday. The Health Ministrys covid19 update on Wednesday said the people who died were eight elderly men, seven elderly women, one middle-aged man, and one middle-aged woman. It said 12 of these people had multiple comorbidities, including a mix of diabetes, hypertension, heart disease, cancer, lung disease, and a history of strokes. Three people had one of the aforementioned medical conditions, while two people had no known medical conditions. There are 516 patients in hospital. Of these, there are 91 people at the Couva Hospital and Multi-Training Facility, with 24 in the intensive care unit and 22 in the high dependency unit.

While Pfizer said Wednesday that a booster of its COVID-19 vaccine may offer important protection against the new omicron variant, health officials in Monterey County do not report the booster shot rate.

As we learned from Schoolhouse Rock, three is a magic number. Pfizer/BioNTech says a total of three jabs of their vaccine is likely to protect against infection with the Omicron variant and that two doses may not be enough, according to new laboratory data that will increase pressure to speed up booster programs. Tests using The post Pfizer Recommends a Total of Three Vaccinations to Fend Off Omicron Variant appeared first on HillReporter.com .